Samuel Washington, MD, MAS

Title(s)Assistant Professor, Urology
SchoolSchool of Medicine
Address550 16th Street, #001
San Francisco CA 94158
Phone415-353-7171
ORCID ORCID Icon0000-0002-2467-6115 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California, Davis, Davis, CABS06/2007Genetics; Latin minor
    University of California, San Francisco, San Francisco, CA06/2011Pathways to Careers in Clinical and Translational Research Yearlong Fellowship
    University of California, San Francisco, San Francisco, CAMD06/2012Medicine
    University of California, San Francisco, San Francisco, CA06/2018Urology surgical Residency
    University of California, San Francisco, San Francisco, CAUrologic Oncology Fellowship
    University of California, San Francisco, San Francisco, CAMAS06/2019Advanced Training in Clinical & Translational Research Program
    University of California, San Francisco, San Francisco, CA06/2024UCSF Health Executive Leadership Academy
    University of California, San Francisco, San Francisco, CA03/2025Foundations for Excellence in Leadership Program
    Collapse awards and honors
    Western Section American Urological Association2024Second Place, Joseph F. McCarthy Physician Essay Contest
    Western Section American Urological Association2023First place, Poster Session
    ConcertAI2021Engaging Research to Achieve Cancer Care Equity Research Award
    San Francisco VA Health Care System2021Grunfeld Scholars
    University of California, San Francisco2021John A. Watson Faculty Scholar
    University of California, San Francisco2021Goldberg-Benioff Endowed Professorship in Cancer Biology
    Bladder Cancer Advocacy Network2019John Quale Travel Fellowship
    Region 5 Geographic Management of Cancer Health Disparities Program201912th American Association of Cancer Researchers Conference on The Science of Cancer Health Dispariti
    OptumLabs – University of California Partnership2019OptumLabs Health Data for Action: Leveraging Health Data for Actionable Insights Data Access Award
    43rd Annual Northern California Residents’ Research Seminar, First Place for Clinical Science Sectio2017Interaction between Histologic Subtype and Ethnicity on Bladder Cancer Outcome
    Miley B. Wesson Resident Essay Contest, Third Place; Western Section American Urological Association2016Incidence of Prostate Cancer within Skeletal Muscle at the Prostate Apex in Men Undergoing Radical P

    Collapse Overview 

    Collapse Research 
    Collapse research activities and funding
    Multilevel assessment of social needs and partnering with community stakeholders to prospectively address local barriers to prostate cancer care
    Prostate Cancer Foundation Oct 30, 2024 - Oct 30, 2027
    Role: Principal Investigator
    Description: Prostate Cancer Foundation Young Investigator Award
    Generating and evaluating interventions to drive health equity in Prostate Cancer care
    The Movember Foundation Sep 1, 2024 - Aug 30, 2026
    Role: Principal Investigator
    Local assessment of interest and engagement of Black men for interventions to address barriers to prostate cancer care
    UCSF Helen Diller Family Comprehensive Cancer Center Community-Engaged Research Pilot Project Award May 31, 2024 - Jun 30, 2025
    Role: Principal Investigator
    Understanding association between social risk and guideline concordant treatment for clinically localized prostate cancer
    UCSF Helen Diller Family Comprehensive Cancer Center Prostate Cancer Program Jan 1, 2023 - May 30, 2024
    Role: Principal Investigator
    An Atlas of Human Prostate AcrossAncestries to develop a comprehensive atlas of the human pros-tate at single-cell resolution with a community engagement plan to maximize impact for the public and clinical and scientific communities
    Chan Zuckerberg Initiative DAF P0559192Dec 2, 2021 - Nov 30, 2024
    Role: Co-Principal Investigator
    Drivers of racial disparities in management of advanced prostate cancer: examining local and geo-graphic variations in evaluation and treatment.
    ConcertAI Dec 1, 2021 - Nov 30, 2022
    Role: Principal Investigator
    Impact of socioeconomic status on overutilization of healthcare expenditure in patients with bladder cancer
    OptumLabs 20183Oct 1, 2019 - Oct 1, 2020
    Role: Co-Investigator
    The Differential Impact of Race on Oncologic Outcomes in Elderly Patients with Bladder Cancer: A Population-based Study
    NIA RCMAR/UCSF Center for Aging in Diverse Communities Scholars Program 132016CJul 1, 2018 - Jun 30, 2019
    Role: Co-Principal Investigator
    The Interventions to Reduce Resident Exhaustion and Depersonalization
    UCSF Academy of Medical EducatorsUCSF 1000112Jul 1, 2017 - Jun 30, 2018
    Role: Co-Principal Investigator
    Biomechanical computed tomography facilitates the diagnosis of osteoporosis and fracture prediction in patients with high risk prostate cancer
    US Department of Defense W81XWH-21-PCRP-DSA
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rural-Urban Differences and Socioeconomic Disparities in Long-Term Urinary Adverse Events Following Prostate Cancer Treatment. Urol Pract. 2025 May 27; 101097UPJ0000000000000837. Carlisle MN, Li KD, Jarosek SL, Faris AR, Patel HV, Washington SL, Breyer BN. PMID: 40423551.
      View in: PubMed   Mentions:    Fields:    
    2. Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort. Eur Urol Focus. 2025 May 14. Shee K, Cowan JE, Ding CC, Wang L, Pace W, Greenland N, Simko JP, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 40374413.
      View in: PubMed   Mentions:    Fields:    
    3. Time is on our side - rethinking the concept of time to treatment for prostate cancer. Nat Rev Urol. 2025 May; 22(5):251-252. Palmer NR, Carroll PR, Washington SL. PMID: 39613985.
      View in: PubMed   Mentions:    Fields:    
    4. Bridging the Gap: Enhancing Prostate Cancer Survivorship and Advocacy Among Ethnically Diverse Black Men Through Community Town Halls. J Cancer Educ. 2025 Feb 24. Ogunsanya ME, Kaninjing E, DeForge SM, Morton DJ, Cole P, Beckford P, Reese D, Mitchell T, Montgomery E, Odeleye R, Miró-Rivera EY, Roberts K, Neil JM, Alexander AC, Funk-Lawler RK, Azizoddin D, Roach M, Washington SL, Dwyer K, Young ME, Odedina FT, Kendzor DE. PMID: 39994169.
      View in: PubMed   Mentions:    Fields:    
    5. Disparities in Urine Testing Among Febrile Children in US Emergency Departments. J Racial Ethn Health Disparities. 2025 Feb 17. Kyaw TS, De La Cueva C, Leva N, Goldberg D, Allen IE, Overland M, Washington S, Copp HL. PMID: 39961980.
      View in: PubMed   Mentions:    Fields:    
    6. Mainstreaming improved adoption of germline testing for Veterans Affairs patients with metastatic prostate cancer without exacerbating disparities. Genet Med. 2025 Feb 13; 101383. Scheuner MT, Hoggatt KJ, Sales P, Lerner B, Ferino E, Danowski M, Zhang N, Purmal C, Washington SL, Goodman MM, Ziegler EE, Stoddard AJ, Menendez C, Foote T, Rowe K, McWhirter G, Kelley MJ. PMID: 39959959.
      View in: PubMed   Mentions:    Fields:    
    7. Trends in Prostate Cancer Incidence and Mortality Rates. JAMA Netw Open. 2025 Jan 02; 8(1):e2456825. Van Blarigan EL, McKinley MA, Washington SL, Cooperberg MR, Kenfield SA, Cheng I, Gomez SL. PMID: 39869333; PMCID: PMC11774093.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. County-level racial disparities in prostate cancer-specific mortality from 2005 to 2020. JNCI Cancer Spectr. 2024 Nov 01; 8(6). Washington Iii SL, Fakunle M, Wang L, Braun AE, Leapman M, Cowan JE, Cooperberg MR. PMID: 39495143; PMCID: PMC11631307.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. What's in a Name? Why Words Matter in Advanced Prostate Cancer. Eur Urol. 2025 Feb; 87(2):101-103. Oh WK, Agarwal N, Bryce A, Barata P, Bugler C, Carlsson SV, Cornell B, Dahut W, George D, Loeb S, Montgomery B, Morris D, Mucci LA, Omlin A, Palapattu G, Riaz IB, Ryan C, Schoen MW, Washington SL, Gillessen S. PMID: 39472202.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer. J Urol. 2025 Jan; 213(1):34-39. Fakunle MO, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Carroll PR. PMID: 39383376.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Determining Long-term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance. Eur Urol Oncol. 2025 Apr; 8(2):380-386. Shee K, Nie J, Cowan JE, Wang L, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 39341710.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Association of household net worth with healthcare costs after radical cystectomy using real-world data. Cancer Med. 2024 Apr; 13(7):e7116. Washington SL, Lonergan PE, Odisho AY, Meng MV, Porten SP. PMID: 38553953; PMCID: PMC10980929.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Qualitative Study on Internet Use and Care Impact for Black Men With Prostate Cancer. Health Educ Behav. 2024 06; 51(3):359-366. Loeb S, Sanchez Nolasco T, Byrne N, Allen L, Langford AT, Ravenell JE, Gomez SL, Washington SL, Borno HT, Griffith DM, Criner N. PMID: 38366884.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. The Future State of Race/Ethnicity in Urology: Urology Workforce Projection From 2021-2061. Urology. 2024 05; 187:39-45. Appleton A, Black K, Sellke NC, Washington SL, Does S, Rhodes S, Downs TM, Saigal C, Vince RA, Ghanney Simons EC. PMID: 38354914.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Representation Matters: Trust in Digital Health Information Among Black Patients With Prostate Cancer. J Urol. 2024 Mar; 211(3):376-383. Loeb S, Sanchez Nolasco T, Byrne N, Allen L, Langford AT, Ravenell J, Gomez SL, Washington SL, Borno HT, Griffith DM, Criner N. PMID: 38329047.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life. Urol Oncol. 2024 02; 42(2):28.e9-28.e20. Smani S, Novosel M, Sutherland R, Jeong F, Jalfon M, Marks V, Rajwa P, Nolazco JI, Washington SL, Renzulli JF, Sprenkle P, Kim IY, Leapman MS. PMID: 38161105.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Engaging communities to inform the development of a diverse cohort of cancer survivors: formative research for the eat move sleep study (EMOVES). Res Involv Engagem. 2023 Dec 11; 9(1):117. Andemeskel G, Palmer NR, Pasick R, Van Blarigan EL, Kenfield SA, Graff RE, Shaw M, Yu W, Sanchez M, Hernandez R, Washington SL, Shariff-Marco S, Rhoads KF, Chan JM. PMID: 38082391; PMCID: PMC10712178.
      View in: PubMed   Mentions: 1  
    18. The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort. Eur Urol Oncol. 2024 Aug; 7(4):838-843. Shee K, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 38057193.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Prostate cancer risk stratification using magnetic resonance imaging-ultrasound fusion vs systematic prostate biopsy. JNCI Cancer Spectr. 2023 10 31; 7(6). Khajir G, Press B, Lokeshwar S, Ghabili K, Rahman S, Gardezi M, Washington S, Cooperberg MR, Sprenkle P, Leapman MS. PMID: 38085220; PMCID: PMC10733209.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. Eur Urol. 2024 Jun; 85(6):565-573. Herlemann A, Cowan JE, Washington SL, Wong AC, Broering JM, Carroll PR, Cooperberg MR. PMID: 37858454.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    21. Inequities in Definitive Treatment for Localized Prostate Cancer Among Those With Clinically Significant Mental Health Disorders. Urol Pract. 2023 11; 10(6):656-663. Cabral J, Holt SK, Washington SL, Dwyer E, Lee JR, Wolff EM, Gore JL, Nyame YA. PMID: 37754206; PMCID: PMC10681572.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Ten-year work burden after prostate cancer treatment. Cancer Med. 2023 Sep; 12(18):19234-19244. Washington SL, Lonergan PE, Cowan JE, Zhao S, Broering JM, Palmer NR, Hicks C, Cooperberg MR, Carroll PR. PMID: 37724617; PMCID: PMC10557888.
      View in: PubMed   Mentions: 1     Fields:    
    23. The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement. Prostate Cancer Prostatic Dis. 2024 Dec; 27(4):579-581. Javier-DesLoges J, Dall'Era MA, Brisbane W, Chamie K, Washington SL, Chandrasekar T, Marks LS, Nguyen H, Daneshvar M, Gin G, Kane CJ, Bagrodia A, Cooperberg MR. PMID: 37553435.
      View in: PubMed   Mentions: 3     Fields:    
    24. Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial. Eur Urol. 2023 12; 84(6):588-596. Djaïleb L, Armstrong WR, Thompson D, Gafita A, Farolfi A, Rajagopal A, Grogan TR, Nguyen K, Benz MR, Hotta M, Barbato F, Ceci F, Schwarzenböck SM, Unterrainer M, Zacho HD, Juarez R, Cooperberg M, Carroll P, Washington S, Reiter RE, Eiber M, Herrmann K, Fendler WP, Czernin J, Hope TA, Calais J. PMID: 37482512.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    25. Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes. Eur Urol Oncol. 2024 Apr; 7(2):222-230. Chappidi MR, Sjöström M, Greenland NY, Cowan JE, Baskin AS, Shee K, Simko JP, Chan E, Stohr BA, Washington SL, Nguyen HG, Quigley DA, Davicioni E, Feng FY, Carroll PR, Cooperberg MR. PMID: 37474400.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    26. Explainable ML models for a deeper insight on treatment decision for localized prostate cancer. Sci Rep. 2023 07 17; 13(1):11532. Han JH, Lee S, Lee B, Baek OK, Washington SL, Herlemann A, Lonergan PE, Carroll PR, Jeong CW, Cooperberg MR. PMID: 37460568; PMCID: PMC10352331.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. The Effect of Racial Concordance on Patient Trust in Online Videos About Prostate Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2023 07 03; 6(7):e2324395. Loeb S, Ravenell JE, Gomez SL, Borno HT, Siu K, Sanchez Nolasco T, Byrne N, Wilson G, Griffith DM, Crocker R, Sherman R, Washington SL, Langford AT. PMID: 37466938; PMCID: PMC10357333.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    28. Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer. Urol Oncol. 2023 10; 41(10):429.e9-429.e14. Baskin A, Cowan JE, Braun A, Lonergan PE, Mohamad O, Washington SL, Zhao S, Broering JM, Cooperberg MR, Breyer BN, Carroll PR. PMID: 37407420.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Readmissions trends following radical cystectomy for bladder cancer unchanged in the era of enhanced recovery after surgery (ERAS) protocols. Urol Oncol. 2023 08; 41(8):355.e19-355.e28. Chappidi MR, Escobar D, Meng MV, Washington SL, Porten SP. PMID: 37258373.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer. Urology. 2023 08; 178:114-119. Lonergan PE, Baskin A, Greenberg SA, Mohamad O, Washington SL, Zhao S, Cowan JE, Broering JM, Nguyen HG, Cooperberg MR, Breyer BN, Carroll PR. PMID: 37244430.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging. J Urol. 2023 08; 210(2):281-289. Chang K, Greenberg SA, Cowan JE, Parker R, Shee K, Washington SL, Nguyen HG, Shinohara K, Carroll PR, Cooperberg MR. PMID: 37099018.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    32. PSA density does not improve predictive accuracy of the UCSF-CAPRA score. Prostate. 2023 07; 83(10):922-928. Parker R, Bell A, Chang K, Greenberg S, Washington SL, Cowan JE, Carroll PR, Cooperberg MR. PMID: 37078628.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Prostate cancer disparities among American Indians and Alaskan Natives in the United States. J Natl Cancer Inst. 2023 04 11; 115(4):413-420. Chu CE, Leapman MS, Zhao S, Cowan JE, Washington SL, Cooperberg MR. PMID: 36629492; PMCID: PMC10086629.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States. World J Mens Health. 2023 Oct; 41(4):940-950. Han JH, Herlemann A, Washington SL, Lonergan PE, Carroll PR, Cooperberg MR, Jeong CW. PMID: 37118954; PMCID: PMC10523124.
      View in: PubMed   Mentions: 2  
    35. Limited Relevance of the Very Low Risk Prostate Cancer Classification in the Modern Era: Results from a Large Institutional Active Surveillance Cohort. Eur Urol. 2023 07; 84(1):9-12. Shee K, Cowan JE, Balakrishnan A, Escobar D, Chang K, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 36870794.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. Eur Urol Oncol. 2023 Oct; 6(5):501-507. Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll PR, Mohamad O. PMID: 36868922.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    37. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. J Natl Compr Canc Netw. 2023 03; 21(3):236-246. Moses KA, Sprenkle PC, Bahler C, Box G, Carlsson SV, Catalona WJ, Dahl DM, Dall'Era M, Davis JW, Drake BF, Epstein JI, Etzioni RB, Farrington TA, Garraway IP, Jarrard D, Kauffman E, Kaye D, Kibel AS, LaGrange CA, Maroni P, Ponsky L, Reys B, Salami SS, Sanchez A, Seibert TM, Shaneyfelt TM, Smaldone MC, Sonn G, Tyson MD, Vapiwala N, Wake R, Washington S, Yu A, Yuh B, Berardi RA, Freedman-Cass DA. PMID: 36898362.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    38. Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare system. Cancer Med. 2023 03; 12(6):6945-6955. Caram MEV, Kumbier K, Burns J, Sparks JB, Tsao PA, Stensland KD, Washington SL, Hollenbeck BK, Shahinian V, Skolarus TA. PMID: 36790037; PMCID: PMC10067072.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. The natural history of a delayed detectable PSA after radical prostatectomy. Prostate Cancer Prostatic Dis. 2023 Dec; 26(4):759-764. Szymaniak JA, Washington SL, Cowan JE, Cooperberg MR, Lonergan PE, Nguyen HG, Meng MV, Carroll PR. PMID: 36765111; PMCID: PMC10638081.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Urologists in Advocacy: The Key to Addressing Disparities in Prostate Cancer. J Urol. 2023 01; 209(1):27-28. Pittman A, Moses KA, Washington SL. PMID: 36394976.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Someone Like Me: An Examination of the Importance of Race-Concordant Mentorship in Urology. Urology. 2023 01; 171:41-48. Penaloza NG, E Zaila Ardines K, Does S, Washington SL, Tandel MD, Braddock CH, Downs TM, Saigal C, Ghanney Simons EC. PMID: 36272563.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    42. Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. J Urol. 2023 01; 209(1):198-207. Shee K, Washington SL, Cowan JE, de la Calle CM, Baskin AS, Chappidi MR, Escobar D, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 36067374.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. We Must Change Our Approach to Racial Disparities in Prostate Cancer. Eur Urol. 2022 10; 82(4):352-353. Washington SL. PMID: 35934600.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Racial and Ethnic Differences in Medical Student Timing and Perceived Quality of Exposure to Urology. Urology. 2022 10; 168:50-58. Ghanney Simons EC, Ardines KEZ, Penaloza NG, Does S, Washington SL, Tandel MD, Braddock CH, Downs TM, Saigal C. PMID: 35718136.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer. JAMA Oncol. 2022 05 01; 8(5):687-696. Leapman MS, Dinan M, Pasha S, Long J, Washington SL, Ma X, Gross CP. PMID: 35238879; PMCID: PMC8895315.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    46. EDITORIAL COMMENT. Urology. 2022 04; 162:26. Washington SL. PMID: 35469609.
      View in: PubMed   Mentions:    Fields:    
    47. The effect of preoperative membranous urethral length on likelihood of postoperative urinary incontinence after robot-assisted radical prostatectomy. Prostate Cancer Prostatic Dis. 2022 02; 25(2):344-350. Greenberg SA, Cowan JE, Lonergan PE, Washington SL, Nguyen HG, Zagoria RJ, Carroll PR. PMID: 35352026.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    48. The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate Cancer. J Urol. 2022 05; 207(5):1001-1009. Chappidi MR, Bell A, Cowan JE, Greenberg SA, Lonergan PE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 34981949.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Compliance with Percutaneous Tibial Nerve Stimulation at a Tertiary Academic Center versus a County Hospital. J Health Care Poor Underserved. 2022; 33(3):1569-1582. Dong A, Nabavizadeh R, Jiang JF, Washington SL, Master VA. PMID: 36245181.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Translating Patient-Centered Research into Educational Resources to Address Racial Inequities in Prostate Cancer. J Urol. 2022 03; 207(3):496-497. Washington SL, Gore JL, Nyame YA. PMID: 34967664.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer. J Urol. 2022 04; 207(4):832-840. Lonergan PE, Washington SL, Cowan JE, Zhao S, Broering JM, Cooperberg MR, Carroll PR. PMID: 34854749.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    52. PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study. J Nucl Med. 2022 Jan; 63(1):76-80. Ferdinandus J, Fendler WP, Farolfi A, Washington S, Mohamad O, Pampaloni MH, Scott PJH, Rodnick M, Viglianti BL, Eiber M, Herrmann K, Czernin J, Armstrong WR, Calais J, Hope TA, Piert M. PMID: 34620731; PMCID: PMC8717195.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    53. Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database. Prostate Cancer Prostatic Dis. 2022 04; 25(4):690-693. Lonergan PE, Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 34508180; PMCID: PMC9705238.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Formal Mentorship as an Opportunity to Expand the Urology Pipeline: Under Represented Trainees Entering Residency (UReTER) Program Evaluation 2020-2021. Urology. 2022 04; 162:108-113. Zheng MY, Overland M, Escobar D, Fakunle M, Li Y, Chu C, Balakrishnan A, Shee K, Washington S, Hampson L. PMID: 34506807.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    55. Trends in the Racial and Ethnic Diversity in the US Urology Workforce. Urology. 2022 04; 162:9-19. Simons ECG, Arevalo A, Washington SL, Does S, Kwan L, Nguyen AV, Downs TM, Braddock CH, Saigal C. PMID: 34469768.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    56. A Cross-Sectional Analysis of Barriers Associated With Non-Attendance at a Urology Telehealth Clinic in a Safety-Net Hospital. Urology. 2022 04; 162:57-62. Bell A, Lonergan PE, Escobar D, Fakunle M, Chu CE, Berdy S, Palmer NR, Breyer BN, Washington SL. PMID: 34461145.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    57. The state of our understanding of prostate cancer in sub-Saharan Africa. Cancer. 2021 11 15; 127(22):4131-4132. Greenberg SA, Washington SL. PMID: 34328212.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    58. Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort. Prostate. 2021 09; 81(13):1009-1017. Lonergan PE, Cowan JE, Washington SL, Greenberg SA, Nguyen HG, Carroll PR. PMID: 34288004.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    59. Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen. J Urol. 2021 09; 206(3):706-714. Greenberg SA, Washington SL, Lonergan PE, Cowan JE, Baskin AS, Nguyen HG, Odisho AY, Simko JP, Carroll PR. PMID: 33905262.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    60. Editorial Commentary. Urol Pract. 2021 Jul; 8(4):522. Washington SL, Parker R. PMID: 37145486.
      View in: PubMed   Mentions:    Fields:    
    61. Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality. Curr Oncol Rep. 2021 03 10; 23(3):37. Langlais CS, Graff RE, Van Blarigan EL, Palmer NR, Washington SL, Chan JM, Kenfield SA. PMID: 33689041; PMCID: PMC7946660.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    62. EDITORIAL COMMENT. Urology. 2021 02; 148:209-210. Washington SL, Nyame YA. PMID: 33549216.
      View in: PubMed   Mentions:    Fields:    
    63. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2022 10; 5(5):537-543. Chu CE, Cowan JE, Lonergan PE, Washington SL, Fasulo V, de la Calle CM, Shinohara K, Westphalen AC, Carroll PR. PMID: 33483265.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    64. Supporting Black voices in urology. Nat Rev Urol. 2021 01; 18(1):7-17. Downs TM, Enemchukwu E, Lee CT, Moses KA, Nyame YA, Powell IJ, Vince R, Williams H, Wilson S, Washington SL. PMID: 33318668; PMCID: PMC7734897.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy. Urology. 2021 Mar; 149:168-173. Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP. PMID: 33278460.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    66. Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US. JAMA Netw Open. 2020 12 01; 3(12):e2031349. Washington SL, Jeong CW, Lonergan PE, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 33369661; PMCID: PMC7770559.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    67. The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide? J Urol. 2021 Jan; 205(1):109-114. Chu CE, Cowan JE, Fasulo V, Washington SL, de la Calle C, Shoemaker J, Carroll PR. PMID: 33198555.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. Health literacy and shared decision making in prostate cancer screening: Equality versus equity. Cancer. 2021 01 15; 127(2):181-183. Washington SL, Master VA. PMID: 33164210.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    69. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 12; 204(6):1222-1228. Maggi M, Cowan JE, Fasulo V, Washington SL, Lonergan PE, Sciarra A, Nguyen HG, Carroll PR. PMID: 33157570.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    70. Monitoring Prostate Cancer Incidence Trends: Value of Multiple Imputation and Delay Adjustment to Discern Disparities in Stage-specific Trends. Eur Urol. 2021 01; 79(1):42-43. Gomez SL, Washington SL, Cheng I, Huang FW, Cooperberg MR. PMID: 33153814.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer. Prostate. 2021 02; 81(2):102-108. Washington SL, Cowan JE, Herlemann A, Zuniga KB, Masic S, Nguyen HG, Carroll PR. PMID: 33075151.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    72. Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy. Eur Urol Oncol. 2022 02; 5(1):61-69. Fasulo V, Cowan JE, Maggi M, Washington SL, Nguyen HG, Shinohara K, Lazzeri M, Casale P, Carroll PR. PMID: 33069628.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    73. Reply by Authors. J Urol. 2020 12; 204(6):1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32969756.
      View in: PubMed   Mentions:    Fields:    
    74. Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer. Cancer Med. 2020 11; 9(22):8310-8317. Washington SL, Gregorich SE, Meng MV, Suskind AM, Porten SP. PMID: 32869516; PMCID: PMC7666728.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    75. How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound? Eur Urol Focus. 2021 Nov; 7(6):1268-1273. Herlemann A, Overland MR, Washington SL, Cowan JE, Westphalen AC, Carroll PR, Nguyen HG, Shinohara K, Cooperberg MR. PMID: 32868222.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    76. Disparities in fertility knowledge among women from low and high resource settings presenting for fertility care in two United States metropolitan centers. Fertil Res Pract. 2020; 6:15. Hoffman JR, Delaney MA, Valdes CT, Herrera D, Washington SL, Aghajanova L, Smith JF, Herndon CN. PMID: 32821417; PMCID: PMC7429753.
      View in: PubMed   Mentions: 5  
    77. Bladder cancer in patients younger than 40 years: outcomes from the National Cancer Database. World J Urol. 2021 Jun; 39(6):1911-1916. de la Calle CM, Washington SL, Lonergan PE, Meng MV, Porten SP. PMID: 32737581.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    78. Correction to: A comparison of stage-specific all-cause mortality between testicular sex cordstromal tumors and germ cell tumors: results from the National Cancer Database. BMC Urol. 2020 07 17; 20(1):103. Zuniga KB, Washington SL, Porten SP, Meng MV. PMID: 32680507; PMCID: PMC7368670.
      View in: PubMed   Mentions:    Fields:    
    79. Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer. Eur Urol. 2020 10; 78(4):515-517. Chu CE, Lonergan PE, Washington SL, Cowan JE, Shinohara K, Westphalen AC, Carroll PR, Cooperberg MR. PMID: 32631744.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    80. Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 12; 204(6):1216-1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32519915.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    81. A comparison of stage-specific all-cause mortality between testicular sex cord stromal tumors and germ cell tumors: results from the National Cancer Database. BMC Urol. 2020 Apr 17; 20(1):40. Zuniga KB, Washington SL, Porten SP, Meng MV. PMID: 32303266; PMCID: PMC7164279.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    82. The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations. Eur Urol. 2020 09; 78(3):335-344. Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 31980309.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    83. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort. AJR Am J Roentgenol. 2020 03; 214(3):574-578. Washington SL, Baskin AS, Ameli N, Nguyen HG, Westphalen AC, Shinohara K, Carroll PR. PMID: 31913068.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    84. Active surveillance for intermediate-risk prostate cancer: yes, but for whom? Curr Opin Urol. 2019 11; 29(6):605-611. Overland MR, Washington SL, Carroll PR, Cooperberg MR, Herlemann A. PMID: 31436567.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    85. What is the Impact of Racial Disparities on Diagnosis and Receipt of Appropriate Mental Health Care Among Urology Patients? Eur Urol Focus. 2020 11 15; 6(6):1155-1157. Washington SL, Nyame YA, Moses KA. PMID: 31542408; PMCID: PMC8544018.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    86. Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2019 10; 202(4):696-701. Cedars BE, Washington SL, Cowan JE, Leapman M, Tenggara I, Chan JM, Cooperberg MR, Carroll PR. PMID: 30958742.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    87. Perspectives From Authors and Editors in the Biomedical Disciplines on Predatory Journals: Survey Study. J Med Internet Res. 2019 08 30; 21(8):e13769. Cohen AJ, Patino G, Kamal P, Ndoye M, Tresh A, Mena J, Butler C, Washington S, Breyer BN. PMID: 31471960; PMCID: PMC6743260.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    88. The Impact of Stone Multiplicity on Surgical Decisions for Patients with Large Stone Burden: Results from ReSKU. J Endourol. 2019 09; 33(9):742-749. Zetumer S, Wiener S, Bayne DB, Armas-Phan M, Washington SL, Tzou DT, Stoller M, Chi T. PMID: 31044624; PMCID: PMC6748398.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    89. Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research. JCO Clin Cancer Inform. 2019 07; 3:1-8. Odisho AY, Bridge M, Webb M, Ameli N, Eapen RS, Stauf F, Cowan JE, Washington SL, Herlemann A, Carroll PR, Cooperberg MR. PMID: 31314550; PMCID: PMC6874052.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    90. Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer. Cancer Epidemiol Biomarkers Prev. 2019 08; 28(8):1339-1344. Washington SL, Neuhaus J, Meng MV, Porten SP. PMID: 31092404; PMCID: PMC6679737.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    91. Altruistic donation to improve survey responses: a global randomized trial. BMC Res Notes. 2019 Feb 28; 12(1):113. Cohen AJ, Washington S, Butler C, Kamal P, Patino G, Tresh A, Mena J, Ndoye M, Breyer BN. PMID: 30819217; PMCID: PMC6396474.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    92. The Association Between Race and Frailty in Older Adults Presenting to a Nononcologic Urology Practice. Urology. 2019 05; 127:19-23. Washington SL, Porten SP, Quanstrom K, Jin C, Bridge M, Finlayson E, Walter LC, Suskind AM. PMID: 30822479; PMCID: PMC6495603.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    93. Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer. Clin Genitourin Cancer. 2019 06; 17(3):e461-e471. Balakrishnan AS, Washington SL, Meng MV, Porten SP. PMID: 30799130.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    94. Health Care Delivery for Metastatic Hormone-sensitive Prostate Cancer Across the Globe. Eur Urol Focus. 2019 03; 5(2):155-158. Herlemann A, Washington SL, Cooperberg MR. PMID: 30587443.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    95. Racial distribution of urology workforce in United States in comparison to general population. Transl Androl Urol. 2018 Aug; 7(4):526-534. Washington SL, Baradaran N, Gaither TW, Awad MA, Murphy GP, Downs TM, Breyer BN. PMID: 30211043; PMCID: PMC6127557.
      View in: PubMed   Mentions: 3  
    96. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2018 10; 1(5):386-394. Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 31158077.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    97. Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier. Urol Clin North Am. 2017 Nov; 44(4):547-555. Herlemann A, Washington SL, Eapen RS, Cooperberg MR. PMID: 29107271.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    98. Web-Based Physician Ratings for California Physicians on Probation. J Med Internet Res. 2017 08 22; 19(8):e254. Murphy GP, Awad MA, Osterberg EC, Gaither TW, Chumnarnsongkhroh T, Washington SL, Breyer BN. PMID: 28830852; PMCID: PMC5585591.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    99. Management of intermediate-risk prostate cancer with active surveillance: never or sometimes? Curr Opin Urol. 2017 May; 27(3):231-237. Masic S, Washington SL, Carroll PR. PMID: 28234748.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    100. Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging. Curr Opin Urol. 2017 May; 27(3):205-209. Eapen RS, Herlemann A, Washington SL, Cooperberg MR. PMID: 28221220.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic Health
    101. Ultrasound-Guided Renal Access and Tract Dilation. Videourology (New Rochelle). 2017; 31(1). Usawachintachit M, Tzou DT, Washington SL, Hu W, Li J, Chi T. PMID: 32292638; PMCID: PMC6964241.
      View in: PubMed   Mentions: 4  
    102. Cystoscopic Evaluation of Bladder Leiomyoma. Urology. 2017 Aug; 106:e1-e2. Washington SL, Eslami A, Tzou DT. PMID: 28161381.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    103. Acute Bladder Necrosis after Pelvic Arterial Embolization for Pelvic Trauma: Lessons Learned from Two Cases of Immediate Postembolization Bladder Necrosis. Case Rep Urol. 2016; 2016:7594192. Washington S, Osterberg EC, Elliott SP, Hittelman AB, Breyer BN. PMID: 27656309; PMCID: PMC5021480.
      View in: PubMed   Mentions: 2  
    104. Current Use of Imaging after Primary Treatment of Prostate Cancer. J Urol. 2015 Jul; 194(1):98-104. Hussein AA, Punnen S, Zhao S, Cowan JE, Leapman M, Tran TC, Washington SL, Truesdale MD, Carroll PR, Cooperberg MR. PMID: 25640648.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    105. Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort. Urology. 2014 Jan; 83(1):33-8. Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll PR. PMID: 24246319.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    106. Out-of-pocket fertility patient expense: data from a multicenter prospective infertility cohort. J Urol. 2014 Feb; 191(2):427-32. Wu AK, Odisho AY, Washington SL, Katz PP, Smith JF. PMID: 24018235.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    107. Benign prostate glandular tissue at radical prostatectomy surgical margins. Urology. 2013 Jul; 82(1):154-9. Odisho AY, Washington SL, Meng MV, Cowan JE, Simko JP, Carroll PR. PMID: 23522995; PMCID: PMC3696410.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    108. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer. BJU Int. 2012 Jul; 110(1):50-5. Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll PR. PMID: 22077660.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    109. Management for prostate cancer treatment related posterior urethral and bladder neck stenosis with stents. J Urol. 2011 Jan; 185(1):198-203. Erickson BA, McAninch JW, Eisenberg ML, Washington SL, Breyer BN. PMID: 21074796; PMCID: PMC3557853.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    110. A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy. Drug Des Devel Ther. 2010 Sep 07; 4:159-71. Washington SL, Shindel AW. PMID: 20856843; PMCID: PMC2939761.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    111. Prostate Cancer: Clinical Case Scenarios. Active Surveillance in African-Americans. Washington, SL III, Cooperberg, MR.
    Samuel's Networks
    Concepts (255)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (82)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.